Literature DB >> 24351024

The importance and necessity of establishing technical specifications for the registration of Traditional Chinese Medicine clinical studies.

Lu Pengfei1, Liao Xing, Xie Yanming, Wang Zhiguo.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24351024      PMCID: PMC3904512          DOI: 10.1089/acm.2013.0353

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


× No keyword cloud information.
  3 in total

1.  [Quality appraisal of systematic reviews or meta-analysis on traditional Chinese medicine published in Chinese journals].

Authors:  Jian-ping Liu; Yun Xia
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2007-04

Review 2.  Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews.

Authors:  Jia He; Liang Du; Guanjian Liu; Jin Fu; Xiangyu He; Jiayun Yu; Lili Shang
Journal:  Trials       Date:  2011-05-13       Impact factor: 2.279

3.  Randomized trials published in some Chinese journals: how many are randomized?

Authors:  Taixiang Wu; Youping Li; Zhaoxiang Bian; Guanjian Liu; David Moher
Journal:  Trials       Date:  2009-07-02       Impact factor: 2.279

  3 in total
  3 in total

1.  Shorter and sturdier bridges between traditional Chinese medicines and modern pharmacology.

Authors:  Abdelaziz Ghanemi; Besma Boubertakh
Journal:  Saudi Pharm J       Date:  2014-03-07       Impact factor: 4.330

2.  Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries.

Authors:  Xuan Zhang; Ran Tian; Zhen Yang; Chen Zhao; Liang Yao; Chungtai Lau; Taixiang Wu; Hongcai Shang; Xiaoyang Zhang; Aiping Lu; Zhaoxiang Bian
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

Review 3.  Chinese Classical Formula Sijunzi Decoction and Chronic Atrophic Gastritis: Evidence for Treatment Approach?

Authors:  Danan Gan; Aili Xu; Hongbo Du; Yong'an Ye
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-24       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.